Chapter 19 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.

Slides:



Advertisements
Similar presentations
Colon Cancer The life time risk of developing Colon Cancer in the United States in one in sixteen. This means 144,000 new cases a year accounting for.
Advertisements

Companion site for Molecular Pathology Author: William B
Chapter 20 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
Chapter 6 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
Familial Colorectal Cancers Francis M. Giardiello, M.D. The Johns Hopkins University.
MSH2 and Human Nonpolyposis Colon Cancer Yael Aschner.
SMAD4/DPC4: A Tumor Suppressor James Brooks March 23 rd, 2006.
34 Cancer.
Colon cancer is the second leading cause of cancer deaths in the U.S. Polyps, the first stage In tumor development
Colon cancer is the second leading cause of cancer deaths in the U.S. Polyps, the first stage In tumor development
NEOPLASIA (Malignant Tumors)
Chapter 4 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
Colorectal carcinoma Dr.Mohammadzadeh.
Familial Cancer. General Principles Mutations inherited through germ cells contribute to a minority of tumours Two hits usually needed germline/somatic.
Β-Catenin, Cancer, and G Proteins Not Just for Frizzleds Anymore Ming Yang et al. PNAS Maria Domenica Castellone et al. Science
Premalignant states n Tubular GI Tract: 1. Esophagus – Barrett’s epithelium 1. Esophagus – Barrett’s epithelium 2. Stomach – dysplasia, IM due to 2. Stomach.
Evaluation Of Colonic Polyps Kathia E. Rosado Orozco MD GI and Liver Pathologist Hato Rey Pathology Associates.
Types of Genes Associated with Cancer
Chapter 11 Cancer Genetics. Cell responses to environmental signals.
NEOPLASIA Dr. Manal Maher Hussein.
Chronic Gastritis and Gastric Cancer
Colon cancer: the second leading cause of cancer deaths in the U.S. Polyps, the first stage In tumor development
Adenoma of the ampulla of vater
Mouse Models of Colon Cancer
Management of Gastric Polyps: An Endoscopy-Based Approach
Pleomorphic adenoma –the tumour at the left side is white gray firm lobulated mass without hemorrhage or necrosis. note the normal lobulated gland at the.
EPIDEMIOLOGY.
Irritable Bowel Syndrome
Gastrointestinal Block Pathology lecture 2016/2017
GIT BLOCK PATHOLOGY PRACTICAL Dr Abdullah Basabein
FAMILIAL ADENOMATOUS POLYPOSIS
Thomas Kirchner, Thomas Brabletz  The American Journal of Pathology 
Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor
Regulation of the Cell Cycle & Cancer
Preinvasive Neoplasia in the Stomach: Diagnosis and Treatment
Bedside to Bench: Role of Muscarinic Receptor Activation in Ultrarapid Growth of Colorectal Cancer in a Patient With Pheochromocytoma  Erik C. von Rosenvinge,
Concept 18.5: Cancer results from genetic changes that affect cell cycle control The gene regulation systems that go wrong during cancer are the very same.
Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor
The Chromosomal Instability Pathway in Colon Cancer
Management of Gastric Polyps: An Endoscopy-Based Approach
Inflammation and Colon Cancer
Mouse Models of Colon Cancer
Genetics of Cancer.
Carcinogenesis of Helicobacter pylori
Colorectal cancer : Three pathways
The promise of cancer genetics
The Multifaceted Role of the Intestinal Microbiota in Colon Cancer
Steven H Itzkowitz, Noam Harpaz  Gastroenterology 
Volume 129, Issue 6, Pages (December 2005)
Caught in the Akt: Regulation of Wnt Signaling in the Intestine
The promise of cancer genetics
Lessons from Hereditary Colorectal Cancer
Intestinal Inflammation and Cancer
Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
BMP Receptor 1a and Juvenile Polyposis Syndrome
Volume 18, Issue 2, Pages (August 2010)
Role of the Serrated Pathway in Colorectal Cancer Pathogenesis
The Morphogenetic Code and Colon Cancer Development
Volume 119, Issue 3, Pages (September 2000)
Volume 15, Issue 3, Pages (March 2014)
Inflammation, Atrophy, Gastric Cancer: Connecting the Molecular Dots
M.B.Ch.B, MSC, PhD, DCH (UK), MRCPCH
AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease  Francis A. Farraye, Robert D. Odze, Jayne.
Molecular Mechanisms Regulating Hair Follicle Development
Colonic polyps and tumors
Dr. Maha Arafah Dr. Ahmed Al Humaidi
A Wnt Survival Guide: From Flies to Human Disease
GPC5 Gene and Its Related Pathways in Lung Cancer
In Vivo Diagnosis and Classification of Colorectal Neoplasia by Chromoendoscopy- Guided Confocal Laser Endomicroscopy  Silvia Sanduleanu, Ann Driessen,
Neoplasia lecture 7 Dr Heyam Awad FRCPath.
Presentation transcript:

Chapter 19 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 2 FIGURE 19.1 Gastric carcinogenesis: Stepwise progression of H. pylor?i?-associated gastric cancer (panels A1–A4), and hereditary diffuse gastric cancer (panels B1 and B2). Panel A1. Chronic active gastritis involving the mucosa of the gastric antrum (H&E stain, original magnification 10×). Panel A2. Immunohistochemical stain highlights H. pylori organisms with typical S and comma shapes, seen at higher magnification in the inset. H. pylori organisms typically appear attached or adjacent to the gastric surface and foveolar epithelium (original magnification 40×). Panel A3. Gastric mucosa with intestinal metaplasia and low-grade dysplasia/adenoma (H&E stain, original magnification 10×). Panel A4. Gastric carcinoma of intestinal type (moderately differentiated adenocarcinoma) (H&E stain, original magnification 10×). Panels B1 and B2 (Courtesy of Dr. Adrian Gologan, Jewish General Hospital, McGill University). Gastric mucosa of patient with hereditary diffuse gastric cancer (HDGC) with in situ signet ring cell carcinoma (arrow) (B1) and invasive signet ring cell carcinoma expanding the lamina propria between the gastric glands (E) (H&E stain, original magnification 20×).

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 3 FIGURE 19.2 Stepwise progression of molecular events during gastric carcinogenesis.

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 4 FIGURE 19.3 Stepwise progression of colorectal neoplasia: progression of neoplasia in sporadic colorectal cancer and in inflammatory bowel disease-associated colitis. In the sporadic colorectal cancer pathway, adenomas characterized in the early stages by low-grade epithelial dysplasia precede the development of high-grade dysplasia, which may then progress to invasive adenocarcinoma. In IBD-associated neoplasia, the background colonic mucosa reveals variable degrees of chronic colitis, and eventually foci of low-grade dysplasia develop, which in turn may progress to high-grade dysplasia and invasive adenocarcinoma. The morphologic features of the neoplastic lesions significantly overlap between sporadic colorectal cancer and IBD-associated neoplasia, but the inflammatory environment that characterizes chronic colitis dictates a number of different molecular mechanisms of neoplastic development and progression.

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 5 FIGURE 19.4 Colorectal cancer pathways: histopathology and molecular correlates. Panels A and B: The serrated pathway. Adenocarcinomas that develop through the serrated pathway arise from serrated polyps that include traditional serrated adenomas. (A) and sessile serrated adenomas (B) (H&E stain, original magnification 5× and 10×, for panels A and B, respectively). Traditional serrated adenomas show both serrated architecture and dysplasia similar to that seen in adenomatous mucosa, whereas sessile serrated adenomas reveal architectural abnormalities but no evidence of classic dysplasia. Panels C and D: The microsatellite instability pathway. Poorly differentiated colonic adenocarcinoma with prominent intratumoral lymphocytes, best seen in the inset (C) (H&E stain, original magnification 10×). By immunohistochemistry, the tumor cells are negative for MSH2, while the surrounding lymphocytes and stromal cells show preserved expression of MSH2 protein in the non-neoplastic cell nuclei (D) immunohistochemistry, original magnification 10×). (E) The presence of microsatellite instability in the tumor DNA is demonstrated by microsatellite instability at the microsatellite markers BAT25 and BAT26 characterized by the appearance of new PCR amplification peaks of smaller size (tailed arrows) as compared to non-neoplastic DNA from the same patient (arrow tip).

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 6 FIGURE 19.5 Molecular events in the stepwise lesions of sporadic colorectal carcinogenesis.

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 7 FIGURE 19.6 Molecular events in the stepwise lesions of inflammatory bowel disease- associated neoplasia.

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 8 FIGURE 19.7 Algorithm for molecular testing of HNPCC/Lynch syndrome colorectal cancer. Modified from Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: A systematic review. Reprinted with permission from JAMA. 2006;296:1507–1517.

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 9 FIGURE 19.8 The Wnt pathway and familial adenomatous polyposis. (A) Signaling of the Wnt pathway is mediated through the Frizzled family of receptors, and a co-receptor LRP5 or 6. In the absence of ligand, the pathway is inactive through the negative regulation of the downstream effector β-catenin. When present in sufficient quantity in the nucleus, β-catenin stimulates transcription of target genes. Lack of signaling through the Frizzled receptor results in sequestration of β- catenin in a multiprotein complex including APC, Axin, and other proteins, which exert a negative effect both through the cytoplasmic sequestration of β-catenin and by targeting it for destruction by the proteasome through phosphorylation. (B) In the presence of Wnt ligand, the Frizzled receptor and LRP5/6 form a complex which results in the recruitment and sequestration of Axin at the cell surface, thereby inhibiting the kinase activity of the APC complex. This results in the stabilization and nuclear translocation of β-catenin, thus resulting in transcription of target genes. (C) In the setting of an APC gene mutation, the multiprotein APC/Axin/β-catenin complex is disrupted, most commonly due to truncation of the APC protein in domains responsible for protein-protein interaction. This results in stabilization and nuclear translocation of β-catenin, with the net effect of constitutively active transcription of growth-promoting genes otherwise under tight regulation. (D) Typical appearance of polyps in FAP, which are indistinguishable from spontaneous nonsyndromic polyps, but are numerous and may eventually cover most of the surface of the colon with a carpet appearance (D1; From the files of the Department of Pathology, Hospital of the University of Pennsylvania). Tubular adenoma (D2) and adenomatous colonic mucosa (D3) at an early stage before the development of larger adenomas and adenocarcinomas (H&E stain, original magnification 5×).

Companion site for Molecular Pathology Copyright © 2009 by Academic Press. All rights reserved. 10 FIGURE 19.9 APC gene mutation and phenotype correlation in FAP. The figure illustrates the APC gene functional domains and mutation-phenotype correlations. The APC protein product consists of 2843 amino acids with multiple functional domains, including a dimerization domain, microtubule domain, and binding sites for β-catenin and axin (pictured as gray boxes). Mutations within certain codon ranges may correlate to a clinical phenotype as depicted in the yellow boxes. Germline mutations generally fall within the entire spectrum of depicted mutational sites, while somatic mutations tend to cluster within the mutation cluster region (MCR). Of note, a profuse polyposis phenotype is seen in patients in whom a germline mutation between codons 1250 and 1464 is seen, with the clinical presentation of >5000 polyps. Mutation at codon 1309 is associated with profuse polyposis and earlier onset of disease. I1307K represents a mutation common in the Ashkenazi Jewish population.